Fundamental dimension Equity attribute | CFLTPeer $30.990.00% Cap $11.08BP/E -47.0x QuantScore36/100 | BLSHLeader $28.21▼-3.36% Cap $4.28BP/E -3.1x QuantScore47/100 | CORZPeer $13.10▼-0.76% Cap $4.21BP/E -3.1x QuantScore36/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
51/100 |
33/100 |
15/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 46/100 | 65/100 | 24/100 |
Growth Revenue / earnings growth & margins | 68/100 | 21/100 | 43/100 |
Sentiment Analyst ratings, targets & revisions | 17/100 | 83/100 | 98/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -47.0x | -3.1x | -3.1x |
Forward P/E (next FY) | 60.6x | 62.6x | -3.0x |
EV / EBITDA (TTM) | -60.4x | -4.3x | -5.0x |
Price / Sales | 12.4x | 0.0x | 9.6x |
Price / Free Cash Flow | 132.8x | 44.1x | -4.3x |
PEG ratio | -1.97 | 0.00 | -0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 4 / 9 | 3 / 9 |
Altman Z-Score | 3.42 (Safe) | 53.68 (Safe) | -2.04 (Distress) |
Total debt / equity | 0.95 | 0.21 | -1.78 |
Quick ratio | 3.8x | 22.4x | 0.9x |
Interest coverage | -136.5x | -0.1x | -5.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +21.1% | -2.1% | -37.5% |
Net income growth YoY | +14.4% | -1073.8% | +78.1% |
Gross margin (TTM) | 74.2% | 0.0% | 28.3% |
Operating margin (FY) | -29.1% | 0.0% | -70.4% |
FCF margin (FY) | 5.2% | -0.0% | -141.3% |
5. Trailing price performancePrice change over period |
1M return | 0.0% | -28.9% | -27.7% |
3M return | +1.5% | +17.7% | -42.4% |
6M return | +37.5% | -29.4% | -37.3% |
Year to date | +2.5% | -25.5% | -10.0% |
1Y return | +44.1% | -48.0% | -32.3% |
3Y return | +27.6% | -58.5% | +280.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $11.24 -63.7% premium | $-131,275.24 -465450.0% premium | $-4.19 -132.0% premium |
Wall Street consensus target | $28.64 -7.6% · range $21.00–$32.00 | $44.00 +56.0% · range $30.00–$61.00 | $32.75 +150.0% · range $16.00–$40.00 |
Consensus stance | 47% Buy50% Hold3% Sell | 60% Buy40% Hold0% Sell | 86% Buy14% Hold0% Sell |